PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 109 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $9,254,000 | -37.5% | 203,156 | -47.9% | 0.06% | -41.7% |
| Q1 2015 | $14,809,000 | -24.6% | 390,109 | -43.7% | 0.11% | -27.5% |
| Q4 2014 | $19,637,000 | +12.0% | 693,397 | 0.0% | 0.15% | +5.7% |
| Q3 2014 | $17,529,000 | -13.4% | 693,397 | 0.0% | 0.14% | -12.4% |
| Q2 2014 | $20,233,000 | +12.7% | 693,397 | 0.0% | 0.16% | +2.5% |
| Q1 2014 | $17,959,000 | +0.6% | 693,397 | 0.0% | 0.16% | +6.8% |
| Q4 2013 | $17,855,000 | -3.7% | 693,397 | 0.0% | 0.15% | +7.3% |
| Q3 2013 | $18,548,000 | +4274.5% | 693,397 | +3921.8% | 0.14% | +4466.7% |
| Q2 2013 | $424,000 | – | 17,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |